Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Mayo Clin Proc. 2014 Feb;89(2):154–162. doi: 10.1016/j.mayocp.2013.10.028

Table 3.

Post-hoc propensity analysis of the patients on ICS.

ICS propensity COPD/asthma Non-COPD/asthma p-value*
Median (1st, 3rd quartile) 0.427 (0.257, 0.594) 0.263 (0.043, 0.480) <0.0001
*

Wilcoxon signed rank test